Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 1.82% 28.00 7,571 08:00:55
Bid Price Offer Price High Price Low Price Open Price
27.00 29.00 28.00 27.50 27.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -7.24 -4.46 57
Last Trade Time Trade Type Trade Size Trade Price Currency
08:00:34 O 3,571 27.8899 GBX

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Takeover Rumours

Futura Medical (FUM) Share Charts

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Intraday Futura Medical Chart

Intraday Futura Medical Chart

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
16/10/201902:57FUTURA a winner for 20156,150
08/7/201909:08one million2
21/1/201909:54www.bluediamondcondom.com59
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414
21/6/201608:43fum reality1

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:00:3527.893,571995.95O
07:00:3427.304,0001,092.00O
2019-10-15 15:12:0627.6310,5392,912.35O
2019-10-15 15:00:1528.102,500702.50O
2019-10-15 14:57:4328.1010,6762,999.95O
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

DateSubject
15/10/2019
09:20
Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 27.50p.
Futura Medical Plc has a 4 week average price of 26.75p and a 12 week average price of 26.50p.
The 1 year high share price is 49p while the 1 year low share price is currently 5.50p.
There are currently 204,660,267 shares in issue and the average daily traded volume is 930,734 shares. The market capitalisation of Futura Medical Plc is £57,304,874.76.
01/10/2019
12:19
j777j: My own view is the share price could reach Liberum's 60p price target upon news of completion of Phase 3 trials in a few days time. As this will be the most significant milestone in the company's history to date. If the trial results in december are a success the share price could head well over 100p.Liberum reckon 145p. Not long to wait. GLA to all patient holders.
29/9/2019
20:28
duwendag: Thebutler and his alter ego Jonnybig should be reported as being one of the same, he must have a short on this stock as well with Iofin. He's Fxxked up on Iofina as their share price has doubled from 15p to 30p so lets hope the same happens with FUM. Theirs nothing wrong in a reasoned argument and discussion for or against a stock, but blatant lying to short a stock is despicable as he has done with Iofin and FUM, all I can say is "karma"
12/9/2019
13:25
glavey: "According to Liberum a successful phase 3 will lead to a 95p share price..." Where do Liberum write that it will lead to a 95p share price?
12/9/2019
11:47
j777j: According to Liberum a successful phase 3 will lead to a 95p share price and they will either do a deal and get funded for next stage or will be easy to raise money on the back of a phase 3 trial which is not a simple binary outcome,as they are many parts and ha s a high probablity of success as they are using a tried and tested drug.One that has an excellent safety profile over decades. They also point out that ex R&D costs are only around £1 million pa as it is an R&D co with low overheads and staff numbers.
25/8/2019
15:09
tommyl1: I wonder if anyone would venture a guess as to what kind of share price FUM could sustain by virtue of TPR alone in the event that Med 2005 ph 3 results were not compelling enough to suit potential commercial partners. Of course there would be an initial bloodbath but for those that hang on long enough there will surely still be value. 30s? 20s?
23/5/2019
12:16
loobrush: New broker -its good news as they can offer much more than previous one and will want toshow how they can do this and get the share price back to a sensible level. In my view some good news is due and they want the new broker to deal with this. Could well be approval for use of the pain products which is due anytime now. Rhat would give abig lift to the share price.
09/1/2019
15:14
lbo: Such a fantastic opportunity that the partner who was supposedly in advanced discussions in March 2018 when the share price was 40p and then completely disappeared and now even at the supposed bargain of 10p has not reappeared with a bid. Never mind even buying shares in the 7p fundraising which was undersubscribed.Mr Barder then backtracked in September and October 2018 and said that raising funds and carrying out phase 3 would add 50% more value to the Med2002 licensing deal yet all the while the share price collapsed from 40p to 7p. So Futura management now need to add 400% in share price value to just get it back to the share price where they claimed they were in advanced discussions with a partner and then claimed by raising funds and completing phase 3 they would add 50% more value to the licensing deal.
02/3/2018
15:12
j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here.
07/6/2017
09:33
mikethebike4: james 'There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. - I have seen this written so many times over the last few years - I will be so shocked when it actually happens I will probably climax on the spot without the aid of Blue Diamond ! - 18 months product is already available from TTK in Asia - why they did not submit for regulatory approval at the same time in Europe I do not know - however I am expecting an announcement by the BoD so that the AGM is not a 'damp squib' MTB4
06/6/2017
22:59
jamesd888: There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here.
Futura Medical share price data is direct from the London Stock Exchange
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191016 07:17:02